טוען...
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
SIMPLE SUMMARY: Immune checkpoint inhibitors have been shown to improve survival in patients with advanced melanoma; however, a proportion of patients do not experience durable clinical benefit with these agents. Findings from a previous study suggested that the use of proton pump inhibitors while r...
Autores principales: | , , , , , , , , , , , , , |
---|---|
פורמט: | Online Artículo Texto |
שפה: | English |
יצא לאור: |
MDPI
2022
|
נושאים: | |
גישה מקוונת: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103038/ https://www.ncbi.nlm.nih.gov/pubmed/35565428 http://dx.doi.org/10.3390/cancers14092300 |